chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A few days after the first one, I had a swollen lymph node in my neck, swelling went down after a couple days; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (A few days after the first one, I had a swollen lymph node in my neck, swelling went down after a couple days) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (A few days after the first one, I had a swollen lymph node in my neck, swelling went down after a couple days). At the time of the report, LYMPHADENOPATHY (A few days after the first one, I had a swollen lymph node in my neck, swelling went down after a couple days) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was not provided by the reporter.   This case was linked to MOD-2021-270166 (Patient Link).
On 12/10/2020 at 9pm patient went to bed with a fever 99.5, pain and chills. Caller took aleve and on Friday patient  called Primary care physician and alerted Nurse of  symptoms. Nurse returned call after speaking with Primary doctor and patient was told to take Tylenol and  stay hydrated.
After about 10 hours, migraine headache started, took prescription pain meds but was not helping.    By 9a.m. my blood pressure taken at home was 180/110 and started having chest pain on left side.    Went to urgent care where they felt it was a cardiac reaction to vaccine and they sent me to ER.   Underwent EKG and chest xray.   Blood pressure still at same level 180/110 and not going down, migraine still at an 8 out of 10, chest pain still present.    I was given an IV to treat for migraine pain and within a few hours all symptoms had went away.   We started with Urgent Care at about 10a.m. on 4/3/21 and then by the time all was done I was released from the ER at 6:30p.m. on 4/3/21.
chills; aches; headache; fever & bed sweats; fever & bed sweats; lethargy; This is a spontaneous report from a contactable consumer (patient). A 41-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route of administration on 17Jan2021 12:00 PM at left arm at single dose for COVID-19 immunization. Medical history was none. No Known allergies. Other medications in two weeks included vitamin c [ascorbic acid], Zinc, Escitalopram 10 MG, Levocentrine. No other vaccine in four weeks. Patient experienced chills, aches, headache, fever & bed sweats, lethargy on 17Jan2021 05:00 PM. No covid prior vaccination. No covid tested post vaccination. It was unknown if treatment was received for the events. Patient was not recovered from the events.  Information about lot/batch number has been requested.
Had Arrhythmias and skipping beats after vaccination; May have been giving 1.5 dose instead of 1 dose; A spontaneous report was received from a consumer concerning a 72 year old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events (arrhythmia, heart rate irregular, Accidental overdose).  The patient's medical history was not provided. Relevant concomitant medication included beta blocker.  On 15Feb2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 024M20A) intramuscularly in the left arm  for prophylaxis of COVID-19 infection.  On 15Feb2021 the patient experienced the events  (arrhythmia) with seriousness criteria (medically significant).  Laboratory details not provided.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the event unknown.; Reporter's Comments: This report refers to a case of accidental overdose for mRNA-1273 (lot # 024M20A) with associated AE reported of arrhythmia. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Very limited information regarding these events has been provided at this time. Further information has been requested.
Pt. was here today to receive immunizations and needing blood work as well. NP verified all immunization/lab work was placed in correctly. I accidentally administered Shingrix vaccine. NDC: 58160-829-03 Lot: E344C Exp: 04/01/2023 right deltoid Dr. was notified and he spoke with the patient and notified him. I apologized as well. All other vaccines and blood work was processed correctly. After agreeing to receive the Boostrix, I administered.
Patient reports arm soreness lasting 7 weeks and continuing to date. Pain occurs when moving arm. Doesn't feel muscle related.
Body chills/aches, followed by an elevated temperature (102), naesua/vomiting, headaches, and lethargy. Fever broke approximately 12 hours after I began to experience body chills with my body temperature returning to normal 28 hours after receiving the 2nd dose.
This spontaneous report was received from a pharmacist (also reported as physician) via other company Pfizer regarding a patient of an unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date in 2005 (reported as 10 years ago), the patient was vaccinated with PNEUMOVAX 23 (Lot number, dose and route of administration were not reported). On an unknown date the patient experienced significant reaction. The outcome of significant reaction was unknown. The reporter did not provide the relatedness of the event with PNEUMOVAX 23. Additional information has been requested.
FEEL SICK FOR LIKE A WEEK AFTER; A spontaneous report has been received from a health professional. The report concerns a male patient (age not provided) of Unknown ethnic origin.    No medical history was reported.     No concomitant products were reported.    The patient received Flumist (influenza virus vaccine live, intranasal) once/single administration, via nasal route, on an unknown date.     On an unknown date, the patient experienced feel sick for like a week after (preferred term: Malaise).     The outcome of feel sick for like a week after was unknown.    The feel sick for like a week after was considered non-serious by reporter.
Perinatal client acknowledged wrong name and received Tdap injection. Had Td on 8/22/08. There is an outbreak of Pertussis in our county at present.
Erythema and edema with localized reaction at vaccine site on left thigh 2 days after receiveing DTaP immunization.
Itching in arm and torso immediately after injection-took standard dose of Benadryl 24 hours after injection, headache and some fatigue-took Ibuprofen 36 hours after injection, migraine, arm pain, fatigue, nausea-took flexiril, Zofran, and Ibuprofen 48 hours after injection, fever of 101, armpit pain, arm pain, fatigue-took Ibuprofen 72 hours after injection arm swollen in 3"x5" oval, bright red, hot to touch, armpit very tender, mild headache-took Ibuprofen
Pt received Janssen vaccine on 03/17/21. Pt presented to the ED on 11/13/21 after being exposed to sick contacts. Pt noted to test positive for COVID on 11/10/21. Pt noted SOB requiring 3L nasal canula.
fever; chills; body aches; cough; Positive COVID-19 test; sore throat; A spontaneous report was received from a deputy health officer concerning a male patient participating in the mRNA-1273 Emergency Use Program and experienced sore throat, fever, chills, body aches and cough. The patient also tested positive for COVID-19.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 26 Dec 2020, approximately 24 hours prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On 27 Dec 2020, the patient was not feeling well after vaccination and had developed sore throat overnight. He was given a COVID-19 rapid test and results returned negative. On 28 Dec 2020, the patient woke up with fever, body aches, chills and cough. He was given a second COVID-19 rapid test and the results returned positive. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The event, positive COVID-19 test, was considered resolved. The outcome of the events, sore throat, fever, chills, body aches and cough was unknown/not reported.; Reporter's Comments: This case concerns a male of unknown age who experienced the nonserious unexpected events of sore throat, cough, and COVID-19, and nonserious expected events of fever, chills, and body aches.  The sore throat occurred within 1 day after the first dose of RNA-1273, and the events of fever, body aches, chills, cough, and a positive COVID-19 test occurred 2 days after mRNA-1273 administration.  Based on the current available information and temporal association between the use of mRNA-1273 and the start date of the events, a causal relationship cannot be excluded.
The patient was given COVID19(Pfizer-BioNTech) 12 -17-year-old vaccine, she should have received the vaccine for 5-11-year-olds. The patient had no adverse reaction to the vaccine.
Reports "difficulty of breathing", chest tightness 1-2 hours post vaccination on 4/27/2021.  Had fever, chills, headaches, rhinorrhea, and watery eyes. Resolved with allegra and Dayquil. Pt came for dose #2 on 5/18. Held dose #2. Need pcp clearance. Question of Allergic reaction vs. covid infection.
parent states that pt awoke on 4OCT96 & w/rash from trunk area of body to feet;rash on anterior trunk occurred;had no fever;APAP has been given 3JUL96;rash gone w/in 5 days;
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Dec2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 54 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Doxycycline, reaction(s): "known allergies:doxycycline", notes: known allergies:doxycycline. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2023) Positive, notes: Recurrence of COVID symptoms & positive rapid test result starting 3 days after last dose of Paxlovid; (2023) Negative, notes: First had a negative Rapid test result on Day 8 and COVID symptoms mostly abated; (2023) Positive, notes: Symptoms resurged and tested positive again on Day 12. Continued having symptoms & testing positive thru Day 20; (2023) Negative, notes: Tested negative again on Days 21 & 22, but still had some lingering symptoms; (2023) Positive, notes: Continued to have symptoms & test positive for COVID for 8 more days. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient received other medication in 2 weeks. Covid-19 treatment was Paxlovid from Mar2023 to Mar2023. Other medication in 2 weeks product was escitalopram, bupropion, ibuprofen, Vit D, fish oil, magnesium. Other medication in 2 weeks brand was generic, start date Jan2023 and stop date was Apr2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Continuous loss of weight; extended fatigue; digestive issues; This is a spontaneous report from a contactable consumer (patient). A 62-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8731), dose 2 via an unspecified route of administration, administered in left arm on an unspecified date as DOSE 2, SINGLE (at the age of 62-years-old) for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EP7534), dose 1 via an unspecified route of administration, administered in left arm on 22Mar2021 as DOSE 1, SINGLE (at the age of 62-years-old) for COVID-19 immunisation. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 13Apr2021, the patient experienced continuous loss of weight, extended fatigue, and digestive issues. The patient received no treatment for the adverse event. The event was considered non-serious and did not result in death/life threatening/ caused/prolonged hospitalization/disabling/incapacitating/congenital anomaly/birth defect. The Outcome of the events was recovering.  Follow-up attempts completed. No further information expected.
Information has been received from a medical assistant referring to a 11 years old patient of unknown gender. The patient's concurrent condition, medical history and concomitant therapy were not reported. On 24-JUL-2017, the patient was vaccinated with the first dose of GARDASIL 9 (lot # N002720, expiration date 12-MAY-2019)  (dose, route of administration and anatomical location were not reported) for prophylaxis. The administered doses of vaccine was exposed to a temperature excursion between 46.8 degrees Fahrenheit (F) which lasted for a 18 hours and 59 degrees Fahrenheit (F) which lasted for 65 hours on 13-JUN-2017. There was 59F previous temperature excursion for 4 hours. Data logger was used to track the temperature. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1708USA005381: US-009507513-1707USA010591: US-009507513-1709USA012722: US-009507513-1709USA012723: US-009507513-1709USA012724: US-009507513-1709USA012725: US-009507513-1709USA012726: US-009507513-1709USA012727: US-009507513-1709USA012728: US-009507513-1709USA012729: US-009507513-1709USA012730: US-009507513-1709USA012731: US-009507513-1709USA012733: US-009507513-1709USA010537: US-009507513-1709USA012776: US-009507513-1709USA012777: US-009507513-1709USA012774:
This spontaneous report as received from a healthcare worker (certified medical assistant) refers to an unspecified number of patients of unknown demographics. No concurrent conditions or medical history were provided. On an unknown date, those patients were vaccinated with a doses of GARDASIL injection (strength, dose, route of administration, indication, lot# and expiry date unspecified), that were improperly stored on unknown dates. No concomitant medications were reported. No adverse effect were reported. Additional information has been requested.
It was reported that a 68 year old female patient received a TD Adult vaccination, intradermal on 26 Jan 2001 at 10:30 am. Reportedly on 27 Jan 2001 at 2:00 pm the patient developed 1cm volar right forearm red and indurated, size down from 4cm on Saturday; itching. Treatment of Benadryl per oral was prescribed. The patient reportedly recovered from this experience.
Headache, Myalgia, Arthralgia, Fever, CHILLS, ITCHY HANDS Narrative:
Develped shingles on right arm and chest lasted for a month, in December had flare up of PMR prescribed prednisone.
Information has been received from a registered nurse concerning a patient who was vaccinated with two dose of ProQuad (Oka/Merck upgrade process) or two doses of Varivax (Oka/Merck). Subsequently, the patient developed a full blown case of chicken pox. The office that reported the case of chicken pox to the public health nurse was not the office that administered the vaccinations. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Small red bumps appeared on forehead and neck, by 7:30pm small bumps were noticed throughout torso area. No fever, no vomiting or any other side effects. By 6:00am, the bumps were bright red, all over his body, and were itchy.
Pt's husband explained that her arm swelled up, and is warm to the touch. She does not have a fever. Explained to husband to let us and dr know of any changes, if pain/warmness increases, she develops a fever, or if it is still warm/painful after 24 hours.
Immediate pain in shoulder at injection site, continuous and increasing pain throughout shoulder area, increasingly limited range of motion and sharp pain when using shoulder. Sharp pain when in inadvertent contact with another person or object. Adhesive capsulitis. Ultrasound showed bone chip at inoculation site and vaccination floating in bursa. MRI confirmed adhesive capsulitis.
Localized redness, non-raised at injection site nickel size. Mother was called. Benadryl PO given per protocol and parent consent.
covid a week after the1st dose of the vaccine. When to get the 2nd dose?/tested positive for COVID; covid a week after the1st dose of the vaccine. When to get the 2nd dose?/tested positive for COVID; body aches; fever; Headache; This is a spontaneous report from a contactable physician.  A 31-year-old female patient (healthcare worker) received the 1st dose of bnt162b2 (BNT162B2) at single dose in Dec2020 (9 days before 07Jan2021) for Covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient received the 1st dose of the COVID vaccine 9 days before 07Jan2021 and got a headache afterward in Dec2020. After 6 days, in Jan2021 the patient had a worse headache, body aches, and fever. She was swabbed for COVID on 06Jan2021 and tested positive. The reporter wanted to know what to do about the 2nd dose. The outcome of events was unknown. A product complaint was filed.  information about lot and batch number was requested.
Had local Rxn of 9 1/2cm x 9 1/2cm swelled, reddened area with 5 blister spots. Area of injection was white looking
45 minutes after vaccine my nose started bleeding. It bled for about 15 minutes.; it was very worrisome; This is a spontaneous report from a contactable consumer (Herself). A 45-years-old non-pregnant female patient received second dose bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 20Apr2021 09:15 as DOSE 2, SINGLE for covid-19 immunization (at the age of 45 years). Medical history included autoimmune thyroiditis from an unknown date and unknown if ongoing. And no known allergies. There were no concomitant medications. The patient previously received first dose bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 22Mar2021 10:0 AM as DOSE 1, SINGLE for covid-19 immunization. The patient was not pregnant at time vaccination. It was reported no other vaccine received in four weeks and also no other medications in two weeks. No covid prior vaccination and also not tested covid post vaccination. The patient experienced on 20Apr2021 10:00 45 minutes after vaccine her nose started bleeding. It bled for about 15 minutes. She never got nose bleeds so it was very worrisome. The patient did not received any treatment. The clinical outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age. On an unknown date (reported as about a year ago), the patient was vaccinated with first dose of GARDASIL, (lot number, expiry date and route was not reported). On 11-JUL-2013, the patient was vaccinated with second dose of GARDASIL, (lot number, expiry date and route was not reported). No adverse event reported was unknown. Additional information is not expected.
On May 27, after the 2nd injection, I became very sick and weak.  This continued for roughly 5 days. I was really dehydrated and blacked out briefly in my living room. Then in early June, I developed a cough that was producing a large amount of mucus. I took cough medicines and decongestants, but nothing seemed to work. The cough got worse - I began coughing up blood -  and was short of breath. On July 9, I went to urgent care and they performed a chest x-ray. They saw the congestion in my left lung and said I had bronchitis, something I have never had before. They prescribed a steroid, cough medicine, and antibiotic. I felt better for a few days but once I was done with the steroid, it got worse again and I went back to the urgent care 2 1/2 weeks later. They conducted another chest x-ray and COVID PCR test (neg). My left lung had not cleared up and my chest was hurting. They prescribed cough medicine with codeine and another round of antibiotics to treat what they thought was severe bronchitis. The cough medicine didn't work, and I have gotten better over time, but as of today, am still coughing up mucus but it is clear now (not bloody or green). The doctor referred me to a pulmonary specialist, whom I haven't yet seen.
Site of flu shot on left arm sore after administration on 10/15/18 and lymph node of left axilla swollen on 10/16/18 per patient.
Patient was given scheduled vaccination doses of: Typhoid, Influenza, and Anthrax on 3/14/09. After about a week and a half later, the patient noticed some mild blistering and itchiness around and below the vaccination site. The blisters and itchiness continued to worsen and spread. Patient finally went to ER on 4/5/09 with purulent lesions that were on the lateral part of their right arm and extending from the deltoid to the forearm. ER diagnosed patient with, "Cutaneous reaction to Anthrax vaccine" and sent patient home with instructions to use hydrocortisone creme. After patient went to the ER, he came to see a military doctor. After our doctor saw the lesions, he commented that it could be a herpes zoster infection secondary to having the vaccines. He concurred with the hydrocortisone therapy. the patient wsa told to let the clinic know if there are any changes, to let us know right away.
General malaise, fatigue, no fever, gradually developed cough. Treated positive for Covid on Friday, July 1 and started on Poxlovid same day. Today I am greatly improved except low energy remains.
first L. upper arm was sore but as the week has progressed.  the pain has spread all the way down to her hand.  Her forearm feels swollen and tight.  No redness or warmth but the entire arm is very tender.  Can barely lift her arm from her side
Patient is fully vaccinated.  Patient presents to the ED secondary to known COVID - 19, reported symptoms for one week, tested +3 days ago. Patient states she is here due to cough, shortness of breath, and intractable diarrhea. Positive for myalgias, fatigue and weakness. Was given fluids. Also given dose of Rocephin here for urinary tract infection. Given Antivert for home use. Patient otherwise stable for discharge. Will return to the ER symptoms worsen. Pt did return 7 days later and was hospitalized.  EMS brought her to the hospital today due to altered mental status and hypoxemia. SPO2 was in the 50s and she was put on non-rebreather mask. Patient was altered and uncooperative at the ER, but she is now able to answer questions appropriately. Treatment:  Lovenox, IV antbiotics, decadron, remdesivir. Pt expired.